Calreticulin negatively regulates the surface expression of Cav1.3 L-type calcium channel

Biochemical and Biophysical Research Communications

Volumn 437, Issue 4, 2013, Pages 497-501

  Karnabi, Eddy ^a,b   Qu, Yongxia ^a   Yue, Yunkun ^a   Boutjdir, Mohamed ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calreticulin; Cav1.3; Fetal myocytes; L type calcium channel

Indexed keywords

CALCIUM CHANNEL CAV1.3; CALCIUM CHANNEL L TYPE; CALRETICULIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM BINDING; CALCIUM CURRENT; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; HEART MUSCLE CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

CALRETICULIN; CAV1.3; FETAL MYOCYTES; L-TYPE CALCIUM CHANNEL;

CALCIUM CHANNELS, L-TYPE; CALRETICULIN; CELL MEMBRANE; DOWN-REGULATION; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; HOMEOSTASIS; HUMANS; KIDNEY; MACROMOLECULAR SUBSTANCES; MYOCYTES, CARDIAC;

EID: 84881552353     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.023     Document Type: Article

References (20)

1. Catterall W.A., Goldin A.L., Waxman S.G. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005, 57:397-409.
2. Hofmann F., Lacinova L., Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev. Physiol. Biochem. Pharmacol. 1999, 139:33-87.
3. Seino S., Chen L., Seino M., Blondel O., Takeda J., Johnson J.H., Bell G.I. Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells. Proc. Natl. Acad. Sci. USA 1992, 89:584-588.
4. Avery R.B., Johnston D. Multiple channel types contribute to the low-voltage-activated calcium current in hippocampal CA3 pyramidal neurons. J. Neurosci. 1996, 16:5567-5582.
5. Platzer J., Engel J., Schrott-Fischer A., Stephan K., Bova S., Chen H., Zheng H., Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell 2000, 102:89-97.
6. Mangoni M.E., Couette B., Bourinet E., Platzer J., Reimer D., Striessnig J., Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proc. Natl. Acad. Sci. USA 2003, 100:5543-5548.
7. Qu Y., Baroudi G., Yue Y., Boutjdir M. Novel molecular mechanism involving alpha1D (Cav1.3) L-type calcium channel in autoimmune-associated sinus bradycardia. Circulation 2005, 111:3034-3041.
8. Qu Y., Karnabi E., Ramadan O., Yue Y., Chahine M., Boutjdir M. Perinatal and postnatal expression of Cav1.3 alpha1D Ca(2)(+) channel in the rat heart. Pediatr. Res. 2011, 69:479-484.
9. Karnabi E., Boutjdir M. Role of calcium channels in congenital heart block. Scand. J. Immunol. 2010, 72:226-234.
10. Qu Y.B., Boutjdir M. Pathophysiology of autoimmune-associated congenital heart block. Appl. Cardiopul. Pathophysiol. 2012, 16:96-112.
11. Wang W.A., Groenendyk J., Michalak M. Calreticulin signaling in health and disease. Int. J. Biochem. Cell Biol. 2012, 44:842-846.
12. Gold L.I., Eggleton P., Sweetwyne M.T., Van Duyn L.B., Greives M.R., Naylor S.M., Michalak M., Murphy-Ullrich J.E. Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J. 2010, 24:665-683.
13. Harada K., Okiyoneda T., Hashimoto Y., Ueno K., Nakamura K., Yamahira K., Sugahara T., Shuto T., Wada I., Suico M.A., Kai H. Calreticulin negatively regulates the cell surface expression of cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 2006, 281:12841-12848.
14. Nakamura K., Robertson M., Liu G., Dickie P., Nakamura K., Guo J.Q., Duff H.J., Opas M., Kavanagh K., Michalak M. Complete heart block and sudden death in mice overexpressing calreticulin. J. Clin. Invest. 2001, 107:1245-1253.
15. Boutjdir M., Chen L., Zhang Z.H., Tseng C.E., DiDonato F., Rashbaum W., Morris A., El-Sherif N., Buyon J.P. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ. Res. 1997, 80:354-362.
16. Chen L., El-Sherif N., Boutjdir M. Unitary current analysis of L-type Ca2+ channels in human fetal ventricular myocytes. J. Cardiovasc. Electrophysiol. 1999, 10:692-700.
17. Tseng C.E., Miranda E., Di Donato F., Boutjdir M., Rashbaum W., Chan E.K., Buyon J.P. MRNA and protein expression of SSA/Ro and SSB/La in human fetal cardiac myocytes cultured using a novel application of the Langendorff procedure. Pediatr. Res. 1999, 45:260-269.
18. Baroudi G., Qu Y., Ramadan O., Chahine M., Boutjdir M. Protein kinase C activation inhibits Cav1.3 calcium channel at NH2-terminal serine 81 phosphorylation site. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:H1614-1622.
19. Mancarella S., Yue Y., Karnabi E., Qu Y., El-Sherif N., Boutjdir M. Impaired Ca2+ homeostasis is associated with atrial fibrillation in the alpha1D L-type Ca2+ channel KO mouse. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H2017-2024.
20. Briassouli P., Rifkin D., Clancy R.M., Buyon J.P. Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-beta and potentiates fibrosis. J. Immunol. 2011, 187:5392-5401.